Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Gillies

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Scientific Reports|June 10, 2022
Neuroimaging and cognitive correlates of retinal Optical Coherence Tomography (OCT) measures at late middle age in a twin sampleChris Moran, Zheng Yang Xu, Hemal Mehta, et al.
Investigative Ophthalmology & Visual Science|August 29, 2017
Conditional Müller Cell Ablation Leads to Retinal Iron AccumulationBailey Baumann, Jacob Sterling, Ying Song, et al.
Journal of Biomechanics|August 2, 2003
A novel method for measuring medial compartment pressures within the knee joint in-vivoIain A Anderson, Andrew A MacDiarmid, M Lance Harris, et al.
Scientific Reports|June 27, 2022
Author Correction: Neuroimaging and cognitive correlates of retinal Optical Coherence Tomography (OCT) measures at late middle age in a twin sampleChris Moran, Zheng Yang Xu, Hemal Mehta, et al.
American Journal of Ophthalmology|October 14, 2019
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two RegionsMark Gillies, Jennifer Arnold, Sanjeeb Bhandari, et al.
Eye (London, England)|December 18, 2025
TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degenerationCarl Regillo, Peter K Kaiser, Peter J Kertes, et al.
The British Journal of Ophthalmology|July 16, 2013
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programmeFrank G Holz, Francesco Bandello, Mark Gillies, et al.
Retina (Philadelphia, Pa.)|February 20, 2020
PREVALENCE AND RISK FACTORS FOR THE DEVELOPMENT OF PHYSICIAN-GRADED SUBRETINAL FIBROSIS IN EYES TREATED FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONKelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|February 8, 2026
Twelve-Month Real-World Outcomes of Faricimab for Treatment-Naive Neovascular AMD in AustraliaMark Gillies, Yohei Hashimoto, Rahman Nazari, et al.
Frontiers in Cellular Neuroscience|December 19, 2019
Differentiation of Retinal Glial Cells From Human Embryonic Stem Cells by Promoting the Notch Signaling PathwaySook Hyun Chung, Weiyong Shen, Kathryn C Davidson, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Scientific Reports|June 10, 2022
Neuroimaging and cognitive correlates of retinal Optical Coherence Tomography (OCT) measures at late middle age in a twin sampleChris Moran, Zheng Yang Xu, Hemal Mehta, et al.
Investigative Ophthalmology & Visual Science|August 29, 2017
Conditional Müller Cell Ablation Leads to Retinal Iron AccumulationBailey Baumann, Jacob Sterling, Ying Song, et al.
Journal of Biomechanics|August 2, 2003
A novel method for measuring medial compartment pressures within the knee joint in-vivoIain A Anderson, Andrew A MacDiarmid, M Lance Harris, et al.
Scientific Reports|June 27, 2022
Author Correction: Neuroimaging and cognitive correlates of retinal Optical Coherence Tomography (OCT) measures at late middle age in a twin sampleChris Moran, Zheng Yang Xu, Hemal Mehta, et al.
American Journal of Ophthalmology|October 14, 2019
Ten-Year Treatment Outcomes of Neovascular Age-Related Macular Degeneration from Two RegionsMark Gillies, Jennifer Arnold, Sanjeeb Bhandari, et al.
Eye (London, England)|December 18, 2025
TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degenerationCarl Regillo, Peter K Kaiser, Peter J Kertes, et al.
The British Journal of Ophthalmology|July 16, 2013
Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programmeFrank G Holz, Francesco Bandello, Mark Gillies, et al.
Retina (Philadelphia, Pa.)|February 20, 2020
PREVALENCE AND RISK FACTORS FOR THE DEVELOPMENT OF PHYSICIAN-GRADED SUBRETINAL FIBROSIS IN EYES TREATED FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONKelvin Yi Chong Teo, Aaron W Joe, Vuong Nguyen, et al.
Clinical & Experimental Ophthalmology|February 8, 2026
Twelve-Month Real-World Outcomes of Faricimab for Treatment-Naive Neovascular AMD in AustraliaMark Gillies, Yohei Hashimoto, Rahman Nazari, et al.
Frontiers in Cellular Neuroscience|December 19, 2019
Differentiation of Retinal Glial Cells From Human Embryonic Stem Cells by Promoting the Notch Signaling PathwaySook Hyun Chung, Weiyong Shen, Kathryn C Davidson, et al.
Pageof 12